A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study.
Autor: | Sim, Hao-Wen, McDonald, Kerrie L, Lwin, Zarnie, Barnes, Elizabeth H, Rosenthal, Mark, Foote, Matthew C, Koh, Eng-Siew, Back, Michael, Wheeler, Helen, Sulman, Erik P, Buckland, Michael E, Fisher, Lauren, Leonard, Robyn, Hall, Merryn, Ashley, David M, Yip, Sonia, Simes, John, Khasraw, Mustafa |
---|---|
Zdroj: | Neuro-Oncology; Oct2021, Vol. 23 Issue 10, p1736-1749, 14p |
Databáze: | Complementary Index |
Externí odkaz: |